Patents by Inventor GLENN LIU

GLENN LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus for Monitoring Treatment Side Effects
    Publication number: 20240164709
    Abstract: A system for monitoring organ health during treatment for cancer and the like makes use of physiological imaging of the kind used for treatment monitoring and organ-specific processing to provide a comprehensive assessment of treatment side-effects.
    Type: Application
    Filed: January 26, 2024
    Publication date: May 23, 2024
    Inventors: Robert Jeraj, Daniel Huff, Timothy Perk, Stephen Yip, Glenn Liu
  • Apparatus for monitoring treatment side effects
    Patent number: 11918374
    Abstract: A system for monitoring organ health during treatment for cancer and the like makes use of physiological imaging of the kind used for treatment monitoring and organ-specific processing to provide a comprehensive assessment of treatment side-effects.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: March 5, 2024
    Assignees: Wisconsin Alumni Research Foundation, AIQ Global, Inc.
    Inventors: Robert Jeraj, Daniel Huff, Timothy Perk, Stephen Yip, Glenn Liu
  • Apparatus for Monitoring Treatment Side Effects
    Publication number: 20210345957
    Abstract: A system for monitoring organ health during treatment for cancer and the like makes use of physiological imaging of the kind used for treatment monitoring and organ-specific processing to provide a comprehensive assessment of treatment side-effects.
    Type: Application
    Filed: April 21, 2021
    Publication date: November 11, 2021
    Inventors: Robert Jeraj, Daniel Huff, Timothy Perk, Stephen Yip, Glenn Liu
  • System and method for evaluation of disease burden
    Patent number: 9603567
    Abstract: A sensitive method of assessing treatment using molecular and anatomical imaging scans provides automatic tumor identification and quantification within anatomical zones based on treatment criteria. Absolute or comparative measures of tumors in pre- and/or post-scans are thereby isolated from other tissue to accentuate the progress of the treatment when multiple scattered disease lesions are present.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: March 28, 2017
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert Jeraj, Glenn Liu
  • System and Method for Evaluation of Disease Burden
    Publication number: 20160100795
    Abstract: A sensitive method of assessing treatment using molecular and anatomical imaging scans provides automatic tumor identification and quantification within anatomical zones based on treatment criteria. Absolute or comparative measures of tumors in pre- and/or post-scans are thereby isolated from other tissue to accentuate the progress of the treatment when multiple scattered disease lesions are present.
    Type: Application
    Filed: October 19, 2015
    Publication date: April 14, 2016
    Inventors: Robert Jeraj, Glenn Liu
  • System and method for evaluation of disease burden
    Patent number: 9161720
    Abstract: A sensitive method of assessing treatment using molecular and anatomical imaging scans provides automatic tumor identification and quantification within anatomical zones based on treatment criteria. Absolute or comparative measures of tumors in pre- and/or post-scans are thereby isolated from other tissue to accentuate the progress of the treatment when multiple scattered disease lesions are present.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 20, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert Jeraj, Glenn Liu
  • System and Method for Evaluation of Disease Burden
    Publication number: 20140276035
    Abstract: A sensitive method of assessing treatment using molecular and anatomical imaging scans provides automatic tumor identification and quantification within anatomical zones based on treatment criteria. Absolute or comparative measures of tumors in pre- and/or post-scans are thereby isolated from other tissue to accentuate the progress of the treatment when multiple scattered disease lesions are present.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: ROBERT JERAJ, GLENN LIU